Barrett RW - Search Results

1

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.

Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW; XP052 Study Group. Kushida CA, et al. Among authors: barrett rw. Neurology. 2009 Feb 3;72(5):439-46. doi: 10.1212/01.wnl.0000341770.91926.cc. Neurology. 2009. PMID: 19188575 Clinical Trial.

2

A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.

Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, Canafax D, Barrett RW; XP021 Study Group. Kushida CA, et al. Among authors: barrett rw. Sleep. 2009 Feb;32(2):159-68. doi: 10.1093/sleep/32.2.159. Sleep. 2009. PMID: 19238802 Free PMC article. Clinical Trial.

3

Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.

Walters AS, Ondo WG, Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW; XP045 Study Group. Walters AS, et al. Among authors: barrett rw. Clin Neuropharmacol. 2009 Nov-Dec;32(6):311-20. doi: 10.1097/WNF.0b013e3181b3ab16. Clin Neuropharmacol. 2009. PMID: 19667976 Clinical Trial.

4

A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW; XP053 Study Group. Lee DO, et al. Among authors: barrett rw. J Clin Sleep Med. 2011 Jun 15;7(3):282-92. doi: 10.5664/JCSM.1074. J Clin Sleep Med. 2011. PMID: 21677899 Free PMC article. Clinical Trial.

5

Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.

Bogan RK, Bornemann MA, Kushida CA, Trân PV, Barrett RW; XP060 Study Group. Bogan RK, et al. Among authors: barrett rw. Mayo Clin Proc. 2010 Jun;85(6):512-21. doi: 10.4065/mcp.2009.0700. Mayo Clin Proc. 2010. PMID: 20511481 Free PMC article. Clinical Trial.

6

Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.

VanMeter SA, Kavanagh ST, Warren S, Barrett RW. VanMeter SA, et al. Among authors: barrett rw. CNS Drugs. 2012 Sep 1;26(9):773-80. doi: 10.2165/11634870-000000000-00000. CNS Drugs. 2012. PMID: 22849331

7

Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.

Hutton JT, Metman LV, Chase TN, Juncos JL, Koller WC, Pahwa R, LeWitt PA, Samii A, Tsui JK, Calne DB, Waters CH, Calabrese VP, Bennett JP, Barrett R, Morris JL. Hutton JT, et al. Mov Disord. 2001 May;16(3):459-63. doi: 10.1002/mds.1085. Mov Disord. 2001. PMID: 11391739 Clinical Trial.

8

A mechanistically novel peptide agonist of the IL-7 receptor that addresses limitations of IL-7 cytokine therapy.

Dower WJ, Park AI, Bakker AV, Cwirla SE, Pongtornpipat P, Williams BM, Joshi P, Baxter BA, Needels MC, Barrett RW. Dower WJ, et al. Among authors: barrett rw. PLoS One. 2023 Oct 24;18(10):e0286834. doi: 10.1371/journal.pone.0286834. eCollection 2023. PLoS One. 2023. PMID: 37874823 Free PMC article.

9

Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists.

Yanofsky SD, Shen ES, Holden F, Whitehorn E, Aguilar B, Tate E, Holmes CP, Scheuerman R, MacLean D, Wu MM, Frail DE, López FJ, Winneker R, Arey BJ, Barrett RW. Yanofsky SD, et al. Among authors: barrett rw. J Biol Chem. 2006 May 12;281(19):13226-13233. doi: 10.1074/jbc.M600601200. Epub 2006 Mar 15. J Biol Chem. 2006. PMID: 16540466 Free article.

10

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys.

Cundy KC, Annamalai T, Bu L, De Vera J, Estrela J, Luo W, Shirsat P, Torneros A, Yao F, Zou J, Barrett RW, Gallop MA. Cundy KC, et al. Among authors: barrett rw. J Pharmacol Exp Ther. 2004 Oct;311(1):324-33. doi: 10.1124/jpet.104.067959. Epub 2004 May 14. J Pharmacol Exp Ther. 2004. PMID: 15146029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page